Leen Al-Alami advises private equity and corporate clients in a variety of transactions, both domestic and cross-border, including mergers and acquisitions, divestitures and joint ventures, as well as in general corporate governance matters. Her clients span a wide range of industries, including technology, chemicals, mining, healthcare and life sciences.
Ms. Al-Alami is a 2013 graduate of the University of Pennsylvania Carey Law School, where she was associate editor of the Journal of Business Law. She holds a B.A., cum laude, and an M.A., both from Harvard University. She is a native speaker of English and Arabic, and is fluent in French and conversational in Hebrew.
Areas of Practice
Mergers and Acquisitions
- University of Pennsylvania Carey Law School, J.D., 2013
- Associate Editor, Journal of Business Law
- Harvard University, M.A., 2004
- Harvard University, B.A., cum laude, 2004
- Duane Morris LLP
- Associate, 2020-present
- Kleinbard LLC
- Associate, 2018-2020
- Dechert LLP
- Associate, 2012-2018
- Member, ACG Women’s Committee
Civic and Charitable Activities
Co-Chair, Seeds of Peace Global Leadership Committee
- The Barnes Foundation, Member, Barnes Art Ball Art Committee
- Support Center for Child Advocates, Volunteer Attorney (Child Advocate)
- Author, "Business Roundtable v. SEC: Rising Judicial Mistrust and the Onset of a New Era in Judicial Review of Securities Regulation," University of Pennsylvania Journal of Business Law, Winter 2013
Advised CMS Technologies, Inc. dba Prevenio®, a leading provider of innovative food safety solutions primarily for protein and produce industries, in its $170 million acquisition by JBT Corporation (NYSE: JBT), a global technology solutions provider to high-value segments of the food and beverage industry.
Represented Piramal Pharma Solutions, a contract development and manufacturing organization, in its acquisition of a solid oral dosage drug product manufacturing facility owned by G&W Laboratories, Inc.
Represented QuadGen Wireless Solutions, a provider of end-to-end telecommunications solutions, in its acquisition by a subsidiary of MasTec, Inc. (NYSE: MTZ)
Represented Bold Technologies, a leading provider of alarm monitoring software, in its acquisition by EverCommerce.
Represented Community Veterinary Partners, an owner of a network of veterinary hospitals, in its acquisition of several veterinary practices.
Represented Vertical Bridge, the largest private owner and manager of communication infrastructure in the U.S., in its acquisition of STC Towers, LLC, a cell tower development company.
Represented Eminent Global Logistics, a transportation management systems implementation and service company, in its acquisition by private equity-backed Redwood Logistics.
Represented Court Square Capital Partners in the sale of The Harvard Drug Group to Cardinal Health for US$1.12 billion.
Represented Court Square Capital Partners and MacDermid Incorporated, a specialty chemical company, in the US$1.8 billion sale of MacDermid to Platform Acquisition Holdings Limited (LSE: PAH).
Represented Graham Partners in the sale of Strata Proximity Systems and Strata Products, a global provider of safety products and services in the mining industry, to Wingate Partners.
Represented Graham Partners in its acquisition of Acme Cryogenics, a manufacturer of cryogenic gas equipment and systems, and its acquisition of OptConnect, a provider of IoT connectivity solutions.
Represented Versa Capital Management in its acquisition of Silver Airways.
Represented Court Square Capital Partners in the US$500 million sale of NMTI Holdings, Inc., a technology company and hotel booking services provider, to Amadeus IT Holdings SA, a leading Spanish travel technology company (AMS.MC).
Represented Crown Holdings, Inc. (NYSE: CCK) in its offering of €650 million senior notes and of €600 million senior notes.
Represented Stripes Group in connection with its participation as lead investor in a Series D financing round of Udemy, Inc.